Endocan Predictive Value in Postcardiac Surgery Acute Respiratory Failure.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-30

Study Completion Date

2017-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

According to literature data, Endocan can detect the onset of respiratory failure. The investigators aim to prove its value also for cardiac surgery patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Predictive Value of Intraoperative Ventilatory Leak Flow in Prolonged Alveolar Air Leak After Lung Resection Surgery

NCT03742739

Pronlongated Alveolar Air Leak (PAAL)

COMPLETED

Use of Point-of-care Lung Ultrasound Before and After Surgery Trying to Predict Post-operative Pulmonary Complications

NCT05502926

Ultrasonography Postoperative Complications Anesthesia +2 more

COMPLETED

Can Point of Care Chest Ultrasound Predicts Pulmonary Complications After Major Surgery?

NCT02979652

Intensive Care, Surgical

UNKNOWN

Oxygen Peripheral Saturations and Lung Surgery

NCT01255033

Pulmonary Surgical Procedures Recovery Period

COMPLETED

Lung Ultrasound in the Early Detection of Postoperative Pulmonary Complications After Esophagectomy

NCT05453760

Esophageal Neoplasm

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Endocan is an endothelium derived soluble dermatan sulfate proteoglycan. Literature data shows that alterate levels of its blood concentration correlate with the onset of pulmonary failure in patients with major trauma and septic shock.

In cardiac surgery respiratory failure and infections are threatening complications leading to mortality rates up to 80%. A rapid diagnosis and treatment of this pathology is crucial to improve the clinical outcome.

Unfortunately specific data for the efficacy of Endocan predictive value in cardiac surgery patients are not available.

The investigators aim to determinate if Endocan can be a helpful tool to identify patients developing acute respiratory failure after cardiac surgery and anticipate specific treatment in order to improve survival.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Failure Postoperative Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients undergoing cardiac surgery

Group Type OTHER

Endocan blood test samples

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endocan blood test samples

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Endocan Endolung

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Able to give written consent
* Elective cardiac surgery
* More than 18 years old

Exclusion Criteria

* Less than 18 years old
* urgency / emergency cardiac surgery
* pregnancy
* refusal
* unable to give written consent
* oncologic patients
* concomitant inflammatory or infective pulmonary disease

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No